Table 1.

Frequency of CD32-, CD25-, CD18-, and CD93-positive cells in 61 primary AML patient BM LSCs. Samples were collected from AML patients with the French-American-British (FAB) subtypes indicated.

FAB	n	Any marker	CD32 or CD25	CD32	CD25	CD18	CD93
M0	2	1	1	1	0	0	0
% Positive		50.0	50.0	50.0	0.0	0.0	0.0
M1	8	7	6	4	2	4	0
% Positive		87.5	75.0	50.0	25.0	50.0	0.0
M2	15	10	6	5	3	5	3
% Positive		66.7	40.0	33.3	20.0	33.3	20.0
M4	4	4	4	3	1	2	1
% Positive		100.0	100.0	75.0	25.0	50.0	25.0
Other	3	3	3	3	0	1	0
% Positive		100.0	100.0	100.0	0.0	33.3	0.0
MDS/AML	29	14	12	5	9	3	0
% Positive		48.3	41.4	17.2	31.0	10.3	0.0
All cases	61	39	32	21	15	15	4
% Positive		63.9	52.5	34.4	24.6	24.6	6.6